DK0504191T3 - Præparat til behandling af HIV-infektioner - Google Patents

Præparat til behandling af HIV-infektioner

Info

Publication number
DK0504191T3
DK0504191T3 DK91900012.5T DK91900012T DK0504191T3 DK 0504191 T3 DK0504191 T3 DK 0504191T3 DK 91900012 T DK91900012 T DK 91900012T DK 0504191 T3 DK0504191 T3 DK 0504191T3
Authority
DK
Denmark
Prior art keywords
treatment
preparation
hiv infections
mammal
infected cells
Prior art date
Application number
DK91900012.5T
Other languages
Danish (da)
English (en)
Inventor
Erfle Volker
Torben Saermark
Original Assignee
Gsf Forschungszentrum F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gsf Forschungszentrum F filed Critical Gsf Forschungszentrum F
Application granted granted Critical
Publication of DK0504191T3 publication Critical patent/DK0504191T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Insects & Arthropods (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK91900012.5T 1989-12-07 1990-12-07 Præparat til behandling af HIV-infektioner DK0504191T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3940526 1989-12-07

Publications (1)

Publication Number Publication Date
DK0504191T3 true DK0504191T3 (da) 1995-03-27

Family

ID=6395034

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91900012.5T DK0504191T3 (da) 1989-12-07 1990-12-07 Præparat til behandling af HIV-infektioner

Country Status (11)

Country Link
EP (1) EP0504191B1 (pt)
JP (1) JPH075475B2 (pt)
KR (1) KR970005329B1 (pt)
AT (1) ATE110278T1 (pt)
AU (1) AU646652B2 (pt)
BR (1) BR9007904A (pt)
DE (2) DE69011870T2 (pt)
DK (1) DK0504191T3 (pt)
ES (1) ES2048137T3 (pt)
GR (1) GR930300031T1 (pt)
WO (1) WO1991008753A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770688A (en) * 1989-12-07 1998-06-23 Gsf-Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Method and composition for the treatment of mammalian HIV infection
DK82892D0 (da) * 1992-06-24 1992-06-24 Michael Hansen Anvendelse af braadgifte fra bier og hvepse til fremstilling af laegemidler til behandling af infektioner
WO1996028563A1 (en) * 1995-03-09 1996-09-19 Bavarian Nordic Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
WO1999018983A1 (en) * 1997-10-15 1999-04-22 Alk-Abelló A/S Composition and method for treating an encephalomyelopathic, demyelinating or autoimmune disease
WO2012093068A1 (en) * 2011-01-03 2012-07-12 F. Hoffmann-La Roche Ag A pharmaceutical composition of a complex of an anti-dig antibody and digoxigenin that is conjugated to a peptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856936A (en) * 1973-05-07 1974-12-24 Schuyler Dev Corp Composition and method for cortisol control

Also Published As

Publication number Publication date
WO1991008753A1 (en) 1991-06-27
EP0504191B1 (en) 1994-08-24
AU646652B2 (en) 1994-03-03
JPH075475B2 (ja) 1995-01-25
GR930300031T1 (en) 1993-06-07
DE69011870D1 (de) 1994-09-29
ES2048137T3 (es) 1994-10-16
ES2048137T1 (es) 1994-03-16
AU6880891A (en) 1991-07-18
EP0504191A1 (en) 1992-09-23
DE504191T1 (de) 1993-04-08
KR970005329B1 (ko) 1997-04-15
BR9007904A (pt) 1992-09-29
ATE110278T1 (de) 1994-09-15
JPH05504761A (ja) 1993-07-22
DE69011870T2 (de) 1994-12-15

Similar Documents

Publication Publication Date Title
DK143088D0 (da) Praeparat til behandling eller forhindring af virale infektioner
SE8702907D0 (sv) Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same
RU94022480A (ru) Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с
DK109487A (da) Fungicid paa basis af et cyanopyrrolderivat
GEP20002297B (en) Alpha-Substituted Pyrimidine-Thioalhyl and Alkyl-Ether Compounds, Method for Treatment of Individual Infected with the Immunodeficiency Virus
GR3017128T3 (en) Treatment of hiv infections and compounds useful therein.
DK169986A (da) Antigen beslaegtet med glycoproteinet i aids-virus, isaer en praekursor for glycoproteinet, og fremgangsmaade til fremstilling af et saadant antigen
DE68906735D1 (de) Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.
ATE6201T1 (de) Verfahren zur lyophilisierung lebender viruszusammensetzungen.
DK538888D0 (da) Anvendelse af castanosperminestere til fremstilling af et farmaceutisk praeparat
DK0504191T3 (da) Præparat til behandling af HIV-infektioner
SE7803615L (sv) Preparat for behandling av herpes zoster och andra herpesinfektioner jemte forfarande for dess framstellning
ES8504459A1 (es) Procedimiento para preparar factor de transferencia especifico a un virus determinado.
DE69133077D1 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
HK148296A (en) Vaccine for use in the therapeutic treatment of hsv
DK0579488T3 (da) Præparat til behandling af mastitis og matritis
DK462688D0 (da) Anvendelse af nukleosider til fremstilling af laegemiddel til behandling af sygdomme foraarsaget af retrovirus eller hepatitis b virus
DK37187D0 (da) Farmaceutisk praeparat til prophylaxe og behandling af virusinfektioner
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
ATE155795T1 (de) Verwendung von leukoregulin zur behandlung von mit einem envelope-virus infizierten tier
ATE85215T1 (de) Antivirales therapeutikum.
MC2306A1 (fr) Peptides bloquant les infections par le virus de l'immunodeficience humaine et methode de leur utilisation
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.
IT8048117A0 (it) Composizione per il trattamento di infezioni virali e procedimento di preparazione